Norman David Eansor

Insider Reports History

Location
Littleton, CO
Signature
/s/ Julio C. Esquivel as Attorney-In-Fact for Norman David Eansor
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Norman David Eansor:

Company Role Class Num Shares Value Price $ Report Date Ownership
BIO-TECHNE Corp President-Protein Sciences Common Stock 2,117 $163,898 $77.42 16 Nov 2021 Direct
BIO-TECHNE Corp President-Protein Sciences Restricted Stock Units 1,556 $124,974 $80.32 12 Nov 2021 Direct
Marker Therapeutics, Inc. Director Stock Option (Right to Buy) 137,330 17 Nov 2025 Direct
BIO-TECHNE Corp President-Protein Sciences Stock Options (Right to Buy) 0 16 Nov 2021 Direct

Insider Reports Filed by Norman David Eansor

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MRKR Marker Therapeutics, Inc. 17 Nov 2025 2 $0 4 Director 19 Nov 2025, 16:10
MRKR Marker Therapeutics, Inc. 12 Feb 2025 1 $0 4 Director 14 Feb 2025, 17:18
MRKR Marker Therapeutics, Inc. 24 May 2022 1 $0 4 Director 26 May 2022, 16:08
TECH BIO-TECHNE Corp 12 Nov 2021 14 -$10,192,045 4 President-Protein Sciences 16 Nov 2021, 15:51
TECH BIO-TECHNE Corp 31 Aug 2021 1 -$773,728 4 President-Protein Sciences 02 Sep 2021, 16:49
TECH BIO-TECHNE Corp 06 Aug 2021 6 -$481,338 4 President-Protein Sciences 10 Aug 2021, 18:19
MRKR Marker Therapeutics, Inc. 08 Jun 2021 1 $0 4 Director 10 Jun 2021, 18:54
MRKR Marker Therapeutics, Inc. 16 Mar 2021 5 +$249,988 4 Director 08 Jun 2023, 21:35